February 13, 2026

Heavy AI capital commitments put big tech valuations under scrutiny

Investors are reassessing Big Tech valuations as aggressive AI spending raises questions about timing, returns and capital discipline...

Tekmar wins £4m European offshore wind CPS award

Tekmar Group plc has been awarded a contract in excess of £4 million to deliver its latest Cable Protection Systems to a large European offshore wind..

Mega cap earnings face higher bar

Strong earnings from leading US technology firms highlight that valuation, capital allocation and execution risk now matter as much as headline growth...

Retail moves from volatility to strategic execution

Retail is entering a steadier phase where execution, technology adoption and customer focus will determine which businesses create lasting value...

Oric Pharmaceuticals, Inc. (ORIC) Stock Analysis: Biotech Innovator with Over 105% Potential Upside

Oric Pharmaceuticals, Inc. (NASDAQ: ORIC), a burgeoning player in the biotechnology sector, is capturing the attention of investors with its promising pipeline of cancer therapies and..

MBX Biosciences, Inc. (MBX) Stock Analysis: A Biotech with a 60.79% Potential Upside

MBX Biosciences, Inc. (MBX) is making waves in the biotechnology sector with its focus on precision peptide therapies aimed at treating endocrine and metabolic disorders. With..

Septerna, Inc. (SEPN) Stock Analysis: Biotechnology Pioneer with 31.43% Upside Potential

Septerna, Inc. (SEPN), a burgeoning name in the biotechnology sector, has captured investor attention with its remarkable revenue growth and potential upside. As a clinical-stage biotech..

Abivax SA (ABVX) Stock Analysis: A 22.77% Potential Upside and Strong Buy Consensus

Abivax SA (ABVX), a French biotechnology powerhouse, is drawing significant investor attention with its promising potential upside of 22.77% as indicated by analyst targets. Operating at..

Fortrea Holdings Inc. (FTRE) Stock Analysis: Biotechnology Player with a 60% Upside Potential

As a relatively new entrant in the healthcare sector, Fortrea Holdings Inc. (NASDAQ: FTRE) is making waves in the biotechnology industry. Incorporated in 2023 and headquartered..

AtaiBeckley Inc. (ATAI) Stock Analysis: Unveiling a 247.89% Potential Upside in Revolutionary Mental Health Treatments

For investors with an eye on the healthcare sector, AtaiBeckley Inc. (NASDAQ: ATAI) offers a compelling case of innovation in mental health treatment, coupled with a..

PureTech Health plc (PRTC) Stock Analysis: Unveiling a 542.7% Revenue Growth Potential

PureTech Health plc (PRTC), a biotechnology firm based in Boston, Massachusetts, is quietly making waves in the healthcare sector. With a focus on developing and commercializing..

Neuropace, Inc. (NPCE) Stock Analysis: A 34% Potential Upside Sparks Investor Interest

Neuropace, Inc. (NASDAQ: NPCE), a pioneering player in the healthcare sector, is drawing significant attention from investors. With its focus on medical devices, specifically targeting drug-resistant..

Humacyte, Inc. (HUMA)

⚠️ No article content returned.

..

Xencor, Inc. (XNCR) Investor Outlook: A Biotech Stock with a 148% Potential Upside

Xencor, Inc. (NASDAQ: XNCR) is capturing the attention of investors in the healthcare sector, particularly those interested in biotechnology. The company, based in Pasadena, California, is..

Rapport Therapeutics, Inc. (RAPP) Stock Analysis: A Deep Dive into Its 83% Potential Upside

Rapport Therapeutics, Inc. (NASDAQ: RAPP) is generating significant buzz in the biotechnology sector with its promising pipeline of treatments for central nervous system (CNS) disorders. As..

Autolus Therapeutics plc (AUTL) Stock Analysis: Exploring a 575% Potential Upside in Groundbreaking T Cell Therapies

Autolus Therapeutics plc (NASDAQ: AUTL), a prominent player in the biotechnology sector, is capturing investor attention with its innovative T cell therapies aimed at treating cancer..

AnaptysBio, Inc. (ANAB) Stock Analysis: Unpacking the 23.71% Potential Upside for Investors

AnaptysBio, Inc. (NASDAQ: ANAB), a clinical-stage biotechnology company, has recently captured investor attention due to its promising potential upside of 23.71%. With a market capitalization of..

Sonida Senior Living, Inc. (SNDA): Navigating Healthcare Challenges with a 25.9% Revenue Surge

Sonida Senior Living, Inc. (NYSE: SNDA), a prominent player in the healthcare sector, specializes in providing senior housing and a broad array of care services across..

Standard BioTools Inc. (LAB) Stock Analysis: Unpacking a 39.64% Potential Upside in the Healthcare Sector

Standard BioTools Inc. (NASDAQ: LAB), a prominent player in the medical devices sector, presents an intriguing opportunity for investors with its considerable potential upside of 39.64%...

Celcuity Inc. (CELC) Stock Analysis: A Biotech Powerhouse with 8.9% Potential Upside

Celcuity Inc. (NASDAQ: CELC) is emerging as a compelling player in the biotechnology sector, especially for investors seeking exposure to innovative, clinical-stage companies focused on cancer..

Search

Funds

February 13, 2026

Heavy AI capital commitments put big tech valuations under scrutiny

Investors are reassessing Big Tech valuations as aggressive AI spending raises questions about timing, returns and capital discipline...

Tekmar wins £4m European offshore wind CPS award

Tekmar Group plc has been awarded a contract in excess of £4 million to deliver its latest Cable Protection Systems to a large European offshore wind project...

Mega cap earnings face higher bar

Strong earnings from leading US technology firms highlight that valuation, capital allocation and execution risk now matter as much as headline growth...

Retail moves from volatility to strategic execution

Retail is entering a steadier phase where execution, technology adoption and customer focus will determine which businesses create lasting value...
Search

Funds

February 13, 2026

FTSE 100

Funds